Page last updated: 2024-12-06

benzo(a)pyrene-3,6-quinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Benzo(a)pyrene-3,6-quinone (BaP-3,6-quinone) is a highly reactive and carcinogenic metabolite of benzo(a)pyrene (BaP), a ubiquitous environmental pollutant. It is formed by the enzymatic oxidation of BaP, primarily by cytochrome P450 enzymes. BaP-3,6-quinone is known to bind to DNA and induce mutations, leading to the development of cancer. It is also a potent inducer of oxidative stress and inflammation. Due to its potent carcinogenic activity and role in the development of various cancers, including lung, skin, and bladder cancer, BaP-3,6-quinone has been extensively studied to understand its mechanisms of action and to develop strategies for preventing and treating cancer. Its formation and interaction with cellular targets, particularly DNA, are of particular interest to researchers. Understanding the metabolic pathways involved in the formation of BaP-3,6-quinone and its interactions with cellular components can shed light on the development of cancer and provide insights for developing cancer prevention and treatment strategies.'

Cross-References

ID SourceID
PubMed CID18301
SCHEMBL ID3342416
MeSH IDM0069198

Synonyms (22)

Synonym
benzo(a)pyrene-3,6-dione
brn 2334218
benzo(a)pyrene 3,6-dione
3,6-benzo(a)pyrenequinone
bp-3,6-quinone
ccris 799
benzo(a)pyrene-3,6-quinone
3,6-benzo(a)pyrenedione
benzo[a]pyrene-3,6-dione
64133-78-4
benzo(a)pyrene-3,6-dione, radical ion(1-)
3-07-00-04370 (beilstein handbook reference)
3067-14-9
ct61ydg18c ,
unii-ct61ydg18c
SCHEMBL3342416
AKOS030255114
benzo[a]pyrene-3,6-quinone
DTXSID40952918
benzo[pqr]tetraphene-3,6-dione
STARBLD0003247
pentacyclo[10.6.2.0?,?.0?,??.0??,??]icosa-1(19),2,4,6,9,11,14,16(20),17-nonaene-8,13-dione

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These data suggest that UGT1A7 may be preferentially active toward B[a]P-quinones and that UGT1A7 may represent the PAH-inducible UGT activity previously implicated in protection against toxic redox cycling by B[a]P-3,6-quinone."( Differential protection by rat UDP-glucuronosyltransferase 1A7 against Benzo[a]pyrene-3,6-quinone- versus Benzo[a]pyrene-induced cytotoxic effects in human lymphoblastoid cells.
Crespi, CL; Grove, AD; Kessler, FK; Llewellyn, GC; Ritter, JK; White, KL, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (47.83)18.7374
1990's3 (13.04)18.2507
2000's9 (39.13)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.04 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.22 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]